Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B

Fertility and Sterility

Volumn 84, Issue 6, 2005, Pages 1685-1688

  Chu, Micheline C ^a   Carmina, Enrico ^b   Wang, Jeff ^a   Lobo, Rogerio A ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Inhibin B; Insulin; MIS; Ovarian volume; PCOS

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; INHIBIN B; INSULIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ANOVULATION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUATION; OVARY BLOOD FLOW; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION INHIBITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSATILE HORMONE RELEASE; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY;

ANOVULATION; BIOLOGICAL MARKERS; FEMALE; FOLLICULAR PHASE; GLYCOPROTEINS; HUMANS; INHIBINS; INSULIN; OBESITY; OVARY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TESTICULAR HORMONES;

EID: 28944435737     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.06.026     Document Type: Article

References (24)

1. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, F.H. de Jong Serum anti-Mullerian hormone levels a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
2. R. Fanchin, L.M. Schonauer, C. Righini, J. Guibourdenche, R. Frydman, J. Taieb Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3 Hum Reprod 18 2003 323 327
3. I.A. van Rooij, I. Tonkelaar, F.J. Broekmans, C.W. Looman, G.J. Scheffer, F.H. de Jong Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition Menopause 11 2004 601 606
4. A.G. Mulders, J.S. Laven, M.J. Eijkemans, F.H. de Jong, A.P. Themmen, B.C. Fauser Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility Hum Reprod 19 2004 2036 2042
5. M.E. Fallat, Y. Siow, M. Marra, C. Cook, A. Carrillo Mullerian-inhibiting substance in follicular fluid and serum a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis Fertil Steril 67 1997 962 965
6. C.L. Cook, Y. Siow, A.G. Brenner, M.E. Fallat Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women Fertil Steril 77 2002 141 146
7. J.S. Laven, A.G. Mulders, J.A. Visser, A.P. Themmen, F.H. De Jong, B.C. Fauser Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age J Clin Endocrinol Metab 89 2004 318 323
8. A. La Marca, R. Orvieto, S. Giulini, V.M. Jasonni, A. Volpe, V. De Leo Mullerian-inhibiting substance in women with polycystic ovary syndrome relationship with hormonal and metabolic characteristics Fertil Steril 82 2004 970 972
9. M.J. Gruijters, J.A. Visser, A.L. Durlinger, A.P. Themmen Anti-Mullerian hormone and its role in ovarian function Mol Cell Endocrinol 211 2003 85 90
10. P. Pigny, E. Merlen, Y. Robert, C. Cortet-Rudelli, C. Decanter, S. Jonard Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome relationship to the ovarian follicle excess and to the follicular arrest J Clin Endocrinol Metab 88 2003 5957 5962
11. R.A. Anderson, N.P. Groome, D.T. Baird Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation Clin Endocrinol (Oxf) 48 1998 577 584
12. G.M. Lockwood, S. Muttukrishna, N.P. Groome, D.R. Matthews, W.L. Ledger Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy a possible mechanism regulating emergence of the dominant follicle J Clin Endocrinol Metab 83 1998 1730 1735
13. P. Pigny, C. Cortet-Rudelli, C. Decanter, D. Deroubaix, B. Soudan, A. Duhamel Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome effects of being overweight and relevance to hyperandrogenism Fertil Steril 73 2000 972 977
14. J.S. Laven, B. Imani, M.J. Eijkemans, F.H. de Jong, B.C. Fauser Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility Hum Reprod 16 2001 1359 1364
15. R.J. Norman, C.R. Milner, N.P. Groome, D.M. Robertson Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome Hum Reprod 16 2001 668 672
16. G.M. Lambert-Messerlian, J.E. Hall, P.M. Sluss, A.E. Taylor, K.A. Martin, N.P. Groome Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay J Clin Endocrinol Metab 79 1994 45 50
17. M.W. Elting, J. Kwee, R. Schats, L.T. Rekers-Mombarg, J. Schoemaker The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries J Clin Endocrinol Metab 86 2001 1589 1595
18. J. Adams, S. Franks, D.W. Polson, H.D. Mason, N. Abdulwahid, M. Tucker Multifollicular ovaries clinical and endocrine features and response to pulsatile gonadotropin releasing hormone Lancet 2 1985 1375 1379
19. A.H. Balen, J.S.E. Laven, S.-L. Tan, D. Dewailly Ultrasound assessment of the polycystic ovary international consensus definitions Hum Reprod Update 9 2003 505 514
20. F.Z. Stanczyk, L. Chang, E. Carmina, Z. Putz, R.A. Lobo Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? Am J Obstet Gynecol 165 1991 1837 1842
21. R.A. Lobo, O.A. Kletzky, E.M. Kaptein, U. Goebelsmann Prolactin modulation of dehydroepiandrosterone sulfate secretion Am J Obstet Gynecol 138 1980 632 636
22. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, G. Sullivan Quantitative insulin sensitivity check index a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
23. R. Fleming, L. Harborne, D.T. MacLaughlin, D. Ling, J. Norman, N. Sattar Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment Fertil Steril 83 2005 130 136
24. E. Carmina, A. Longo, R.A. Lobo Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome? Am J Obstet Gynecol 189 2003 1283 1286